DiscoverThe Lancet Gastroenterology & Hepatology in conversation withSanna Nybacka and Magnus Simrén on a trial of low FODMAP diets versus low carbohydrate diets in IBS
Sanna Nybacka and Magnus Simrén on a trial of low FODMAP diets versus low carbohydrate diets in IBS

Sanna Nybacka and Magnus Simrén on a trial of low FODMAP diets versus low carbohydrate diets in IBS

Update: 2024-05-17
Share

Description

Sanna Nybacka and Magnus Simrén (University of Gothenburg) discuss the CARIBS randomised controlled trial of a low FODMAP diet versus a low-carbohydrate diet versus pharmacological treatment in IBS.

Read the full article:
https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00045-1/fulltext?dgcid=buzzsprout_tlv_podcast_generic_langas

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

Comments 
Top Podcasts
The Best New Comedy Podcast Right Now – June 2024The Best News Podcast Right Now – June 2024The Best New Business Podcast Right Now – June 2024The Best New Sports Podcast Right Now – June 2024The Best New True Crime Podcast Right Now – June 2024The Best New Joe Rogan Experience Podcast Right Now – June 20The Best New Dan Bongino Show Podcast Right Now – June 20The Best New Mark Levin Podcast – June 2024
In Channel
Arndt Vogel on the NALIRICC trial of nanoliposomal irinotecan in pretreated advanced biliary tract cancer

Arndt Vogel on the NALIRICC trial of nanoliposomal irinotecan in pretreated advanced biliary tract cancer

2024-07-3118:23

Nancy Baxter on the duration of colorectal cancer risk reduction with a complete colonoscopy

Nancy Baxter on the duration of colorectal cancer risk reduction with a complete colonoscopy

2024-07-0125:05

Sanna Nybacka and Magnus Simrén on a trial of low FODMAP diets versus low carbohydrate diets in IBS

Sanna Nybacka and Magnus Simrén on a trial of low FODMAP diets versus low carbohydrate diets in IBS

2024-05-1723:16

Nuru Noor on the PROFILE trial of biomarker-stratified treatment in newly diagnosed Crohn's disease

Nuru Noor on the PROFILE trial of biomarker-stratified treatment in newly diagnosed Crohn's disease

2024-05-0719:55

Yusuke Shimakawa on a simple score for hepatitis B treatment eligibility in Africa

Yusuke Shimakawa on a simple score for hepatitis B treatment eligibility in Africa

2024-04-2220:54

Mads Israelsen on validating the new steatotic liver disease nomenclature in people with excessive alcohol intake

Mads Israelsen on validating the new steatotic liver disease nomenclature in people with excessive alcohol intake

2024-03-1216:39

Louise Dye on the role of expectancy and gluten in non-coeliac gluten sensitivity

Louise Dye on the role of expectancy and gluten in non-coeliac gluten sensitivity

2024-03-0123:19

Tzu-Chan Hong on the primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region

Tzu-Chan Hong on the primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region

2023-12-1914:40

Sarah Moen on metachronous colorectal cancer risk according to Lynch syndrome pathogenic variant after colectomy

Sarah Moen on metachronous colorectal cancer risk according to Lynch syndrome pathogenic variant after colectomy

2023-11-2914:45

Anna Emilie Kann on the causes of mortality in patients with alcohol-related liver disease

Anna Emilie Kann on the causes of mortality in patients with alcohol-related liver disease

2023-10-1216:19

Robert Krouse on surgical versus non-surgical management of malignant bowel obstruction

Robert Krouse on surgical versus non-surgical management of malignant bowel obstruction

2023-09-1316:31

Marc Rothenberg on a trial of benralizumab in eosinophilic gastritis

Marc Rothenberg on a trial of benralizumab in eosinophilic gastritis

2023-08-1014:29

Michael Pavlides on non-invasive tests for predicting clinical outcomes in non-alcoholic fatty liver disease

Michael Pavlides on non-invasive tests for predicting clinical outcomes in non-alcoholic fatty liver disease

2023-07-1217:41

Jasmohan Bajaj on global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis

Jasmohan Bajaj on global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis

2023-06-0712:48

Adelina Artenie on the incidence of HIV and HCV in people who inject drugs

Adelina Artenie on the incidence of HIV and HCV in people who inject drugs

2023-05-1017:15

Johan Burisch on the costs of inflammatory bowel disease in high-income settings

Johan Burisch on the costs of inflammatory bowel disease in high-income settings

2023-04-1220:00

Edouard Louis on the SPARE trial of infliximab or immunosuppressant withdrawal in Crohn’s disease

Edouard Louis on the SPARE trial of infliximab or immunosuppressant withdrawal in Crohn’s disease

2023-02-0821:30

Paula Ghaneh on the ESPAC5 trial of neoadjuvant therapy in borderline resectable pancreatic cancer

Paula Ghaneh on the ESPAC5 trial of neoadjuvant therapy in borderline resectable pancreatic cancer

2023-01-2320:20

Dan Turner on vedolizumab in children with IBD

Dan Turner on vedolizumab in children with IBD

2023-01-0614:51

Simon Baunwall on faecal microbiota transplantation for first or second Clostridioides difficile infection

Simon Baunwall on faecal microbiota transplantation for first or second Clostridioides difficile infection

2022-11-0915:21

loading
Google Play
Download from Google Play
Castbox
Download from App Store
usUnited States
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Sanna Nybacka and Magnus Simrén on a trial of low FODMAP diets versus low carbohydrate diets in IBS

Sanna Nybacka and Magnus Simrén on a trial of low FODMAP diets versus low carbohydrate diets in IBS

The Lancet Group